Drug intelligence / Profile preview

Yanhouqing Koukang lozenge

Development stage: Unknown
Lead developer: Guangzhou University of Chinese Medicine
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Yanhouqing Koukang lozenge is a Traditional Chinese Medicine (TCM) formulation developed by Shenzhen Longgang Central Hospital for the treatment of acute pharyngitis, specifically the external wind-heat pattern. As a lozenge, it is designed for local application in the oral cavity and throat to alleviate symptoms such as sore throat, inflammation, and discomfort associated with upper respiratory infections. It has been evaluated in Phase 2 clinical trials in China to determine its efficacy, safety, and optimal dosing compared to placebo.

Other names: Yanhouqing Koukang hanpian

Beyond the preview

Go deeper on Yanhouqing Koukang lozenge.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yanhouqing Koukang lozenge.

Explore the full profile